U.S. Interactive Media and Services Stock News

SPX Technologies (SPXC) has wrapped up FY 2025 with fourth quarter revenue of US$637.3 million and basic EPS of US$1.57, while trailing twelve month revenue came in at about US$2.3 billion alongside EPS of US$5.13. Over the past few quarters the company has seen revenue move from US$533.7 million in Q4 2024 to US$637.3 million in Q4 2025, with basic EPS stepping from US$1.22 to US$1.57 over the same period. Those results sit on top of trailing earnings growth of 21.7% and a net margin of...

Cytokinetics (CYTK) has capped FY 2025 with Q4 revenue of US$17.8 million and a basic EPS loss of US$1.52, anchored by a net loss of US$183.0 million. This sets the tone for how investors are reading the latest update against a year of heavy spending. Over recent periods, the company has seen quarterly revenue range from US$1.6 million to US$66.8 million in FY 2025, while basic EPS losses have moved between US$1.12 and US$2.55. This gives a clear picture of a business that is still investing...

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...

AbCellera Biologics (ABCL) closed out FY 2025 with Q4 revenue of US$44.9 million and a basic EPS loss of US$0.03, alongside trailing 12 month revenue of US$75.1 million and a full year basic EPS loss of US$0.49, providing a snapshot of a business still investing heavily ahead of profitability. Over the past few quarters, the company reported revenue of US$4.2 million in Q1 2025, US$17.1 million in Q2, US$9.0 million in Q3 and US$44.9 million in Q4, while quarterly EPS losses moved from...

If you are wondering whether Air Lease is still offering value at its current share price, this article will walk through what the numbers actually say about the stock. With the share price at US$64.85 and returns of 0.1% over 7 days, 0.7% over 30 days, 1.1% year to date, 36.8% over 1 year, 57.7% over 3 years and 50.1% over 5 years, many investors are asking whether expectations and valuation are now in sync. Recent news on Air Lease has focused on its role in supplying aircraft to airlines...

American Integrity Insurance Group closed FY 2025 with fourth quarter revenue of US$68.1 million and basic EPS of US$1.07, rounding out a twelve month stretch that produced total revenue of US$276.5 million and basic EPS of US$5.65. Over the past year, the company has seen revenue move from US$204.4 million to US$276.5 million and basic EPS adjust from US$309.45 to US$5.65 on a trailing twelve month basis, giving investors a detailed view of how the top and bottom lines have evolved. With net...

Golar LNG (NasdaqGS:GLNG) has wrapped up FY 2025 with Q4 revenue of US$132.8 million and basic EPS of US$0.10, rounding out a year in which trailing twelve month revenue sat at US$393.5 million and EPS reached US$0.64. Over the past few quarters, the company has seen revenue range from US$62.5 million in Q1 2025 to US$132.8 million in Q4 2025, with quarterly EPS moving between US$0.08 and US$0.31 across the year. This has set the backdrop for a trailing net profit margin of 18.3% compared...

Allot (NasdaqGS:ALLT) has wrapped up FY 2025 with Q4 revenue of US$28.4 million and basic EPS of US$0.06, alongside trailing twelve month revenue of US$102.0 million and EPS of US$0.08. Over the past few quarters, the company has reported revenue of US$24.9 million in Q4 2024, followed by US$23.2 million in Q3 2024, and then US$23.2 million, US$23.2 million, US$24.1 million, US$26.4 million and US$28.4 million across FY 2025. Over the same period, quarterly EPS moved from US$0.01 in Q4 2024...

Atlanta Braves Holdings (BATRK) has just posted its FY 2025 third quarter numbers, with revenue of $311.5 million, basic EPS of $0.48 and net income of $30.0 million, giving investors a clear snapshot of how the season is flowing through to the bottom line. The company has seen quarterly revenue move from $282.9 million and EPS of $0.47 in Q2 FY 2024 to $290.7 million and $0.16 in Q3 FY 2024, then to $311.5 million and $0.48 in Q3 FY 2025. This sets up a narrative in which investors are...

Taboola.com (TBLA) closed out FY 2025 with Q4 revenue of US$522.3 million and basic EPS of US$0.17, alongside Q4 2024 figures of US$491.0 million in revenue and basic EPS of US$0.10. Over the latest reported periods, revenue has moved from US$433.0 million in Q3 2024 to US$496.8 million in Q3 2025, while basic EPS shifted from a loss of US$0.02 to a profit of US$0.02. This highlights a story in which improving profitability and tighter margins are front and center for investors assessing this...

Valens Semiconductor FY 2025 Earnings Snapshot Valens Semiconductor (VLN) just posted third quarter FY 2025 revenue of US$17.3 million with a basic EPS loss of US$0.07, alongside trailing twelve month revenue of US$67.9 million and a TTM basic EPS loss of US$0.29. The company has seen quarterly revenue move from US$13.6 million in Q2 2024 to US$17.3 million in Q3 2025, while quarterly EPS losses have ranged between US$0.07 and US$0.10 over the same stretch. Investors are likely to focus on...

F5 (NasdaqGS:FFIV) and Scality have expanded their partnership to offer integrated data delivery and security solutions for AI and analytics workloads. The collaboration focuses on secure, scalable and high performance data access across cloud and hybrid environments. The move targets enterprises that need to manage, move and protect large volumes of data to support AI driven initiatives. For investors watching F5, the timing of this partnership comes as the stock trades around $272.03,...

Frontier Group Holdings (ULCC) has drawn fresh attention after filing a US$12.25 million shelf registration for 2,290,108 common shares tied to an ESOP offering, shortly after reporting a full year 2025 net loss. See our latest analysis for Frontier Group Holdings. The share price has moved sharply around these updates, with a 1-day share price return of a 4.92% decline and a 7-day share price return of a 13.27% decline. Over a longer period, the 90-day share price return is a 4.5% gain,...

In the past quarter, Gladstone Land Corporation reported fourth-quarter 2025 sales of US$41.45 million and net income of US$4.21 million, alongside full-year 2025 revenue of US$88.34 million and net income of US$13.53 million. The sharp year-over-year improvement in quarterly sales and earnings contrasts with softer full-year sales, highlighting how recent operational performance may be shifting for this farmland-focused REIT. Next, we’ll consider how this strong quarterly earnings growth,...

Recent performance snapshot Bel Fuse (BELF.A) has drawn fresh attention after a strong recent run, with the share price showing a 19% gain over the past month and a 67% move in the past 3 months. See our latest analysis for Bel Fuse. The recent momentum is building rather than fading, with a 30 day share price return of 19.2% and a 90 day share price return of 67%, alongside a 1 year total shareholder return of 161.2%. If Bel Fuse’s run has you thinking about where else strong trends might...

Digital Turbine, Inc. recently appointed Ben John, a veteran ad-tech and AI leader formerly at Microsoft and Xandr, as Chief Technology Officer to oversee global engineering, product architecture, data-centric scaling, and AI-driven development. This move comes alongside strong year-over-year revenue and EBITDA growth linked to international expansion and AI integration, highlighting management’s focus on turning technical capabilities into operational efficiency and business outcomes. We’ll...

Hims & Hers Health (HIMS) has capped FY 2025 with fourth quarter revenue of US$617.8 million and basic EPS of US$0.09, rounding out a year in which its trailing twelve month revenue reached about US$2.3 billion and basic EPS came in at roughly US$0.57. Over recent periods the company has seen revenue move from US$481.1 million in Q4 2024 to US$617.8 million in Q4 2025, while quarterly basic EPS shifted from US$0.12 a year ago to US$0.09 most recently. This has set up a results season where...

Keurig Dr Pepper (KDP) has wrapped up FY 2025 with fourth quarter revenue of US$4.5 billion and basic EPS of US$0.26, setting the tone for how investors assess the full year. The company has seen quarterly revenue move from US$4.1 billion in Q4 2024 to US$4.5 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 to EPS of US$0.26 over the same period, against a trailing twelve month EPS of US$1.53. With trailing net margin at 12.5% and earnings growth highlighted over the...

In February 2026, Gentherm reported fourth‑quarter 2025 earnings showing net income falling to US$2.99 million from US$15.32 million a year earlier, while quarterly revenue of about US$382.79 million came in ahead of expectations. Alongside weaker profitability, Gentherm issued product revenue guidance of US$1.5 billion to US$1.6 billion for 2026 and US$1.7 billion for 2027, highlighting its ambition to grow beyond automotive into medical and other precision thermal applications. We’ll now...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

If you are wondering whether Regal Rexnord’s current share price really reflects what the business is worth, you are not alone. This article is built to help you assess that question clearly. With the stock at US$223.69 and returns of 2.1% over 7 days, 43.3% over 30 days, 53.1% year to date and 69.7% over 1 year, many investors are asking what is already priced in and what might still be on the table in terms of risk and reward. These moves sit against a backdrop where Regal Rexnord...

Analysts are flagging anticipated revenue declines for Fortive, citing softer demand and slower organic growth expectations. This shift in sentiment follows previously solid quarterly results and points to a possible inflection in the company’s operational outlook. The change comes as investors reassess Fortive’s near term growth profile beyond recent share price moves. For investors watching Fortive, ticker NYSE:FTV, the backdrop is a mix of steady share performance and growing questions...